{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:11:52Z","timestamp":1792195912909,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100008530","name":"Fondo Europeo de Desarrollo Regional","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-024-02488-5","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T11:45:11Z","timestamp":1730979911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["H-NMR metabolomics identifies three distinct metabolic profiles differentially associated with cardiometabolic risk in patients with obesity in the Di@bet.es cohort"],"prefix":"10.1186","volume":"23","author":[{"given":"Enrique","family":"Ozcariz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Guardiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Amig\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Vald\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasima","family":"Oualla-Bachiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Rehues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Rojo-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Ribalta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"2488_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001916","author":"RZ Sharaiha","year":"2023","unstructured":"Sharaiha RZ, Shikora S, White KP, Macedo G, Toouli J, Kow L. <ArticleTitle Language=\"En\">Summarizing Consensus guidelines on obesity management: a Joint, Multidisciplinary Venture of the International Federation for the Surgery of Obesity & Metabolic Disorders (IFSO) and World Gastroenterology Organisation (WGO). J Clin Gastroenterol. 2023. https:\/\/doi.org\/10.1097\/MCG.0000000000001916.","journal-title":"J Clin Gastroenterol"},{"key":"2488_CR2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316101","author":"ME Pich\u00e9","year":"2020","unstructured":"Pich\u00e9 ME, Tchernof A, Despr\u00e9s JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316101.","journal-title":"Circ Res"},{"key":"2488_CR3","doi-asserted-by":"publisher","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes-2023. Diabetes Care. 2023; https:\/\/doi.org\/10.2337\/dc23-S008. PMID: 36507637.","DOI":"10.2337\/dc23-S008"},{"key":"2488_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2018.11.001","author":"KI Avgerinos","year":"2019","unstructured":"Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism. 2019. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.001.","journal-title":"Metabolism"},{"key":"2488_CR5","unstructured":"World health statistics. 2023: Monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240074323. Accessed 4 June 2024."},{"key":"2488_CR6","doi-asserted-by":"publisher","DOI":"10.1159\/000442721","author":"V Yumuk","year":"2015","unstructured":"Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, Toplak H. Obesity management task force of the european association for the study of obesity. European guidelines for obesity management in adults. Obes Facts. 2015. https:\/\/doi.org\/10.1159\/000442721.","journal-title":"Obes Facts"},{"key":"2488_CR7","unstructured":"Weir CB, Jan A, BMI classification percentile and cut off points. 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541070\/. Accessed 12 March 2024."},{"key":"2488_CR8","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1768_17","author":"LP Mayoral","year":"2020","unstructured":"Mayoral LP, Andrade GM, Mayoral EP, Huerta TH, Canseco SP, Rodal Canales FJ, Cabrera-Fuentes HA, Cruz MM, P\u00e9rez Santiago AD, Alpuche JJ, Zenteno E, Ru\u00edz HM, Cruz RM, Jeronimo JH, Perez-Campos E. Obesity subtypes, related biomarkers & heterogeneity. Indian J Med Res. 2020. https:\/\/doi.org\/10.4103\/ijmr.IJMR_1768_17.","journal-title":"Indian J Med Res"},{"key":"2488_CR9","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa004","author":"MH Matthias Bl\u00fcher","year":"2020","unstructured":"Matthias Bl\u00fcher MH. Obesity. Endocr Rev. 2020. https:\/\/doi.org\/10.1210\/endrev\/bnaa004.","journal-title":"Endocr Rev"},{"key":"2488_CR10","doi-asserted-by":"publisher","DOI":"10.7570\/jomes22036","author":"YK Cho","year":"2022","unstructured":"Cho YK, Jung CH. Metabolically healthy obesity: epidemiology, criteria, and implications in chronic kidney disease. J Obes Metab Syndr. 2022. https:\/\/doi.org\/10.7570\/jomes22036.","journal-title":"J Obes Metab Syndr"},{"key":"2488_CR11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4253","author":"F Soriguer","year":"2013","unstructured":"Soriguer F, Guti\u00e9rrez-Repiso C, Rubio-Mart\u00edn E, Garc\u00eda-Fuentes E, Almaraz MC, Colomo N, Esteva de Antonio I, de Adana MS, Chaves FJ, Morcillo S, Vald\u00e9s S, Rojo-Mart\u00ednez G. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab. 2013. https:\/\/doi.org\/10.1210\/jc.2012-4253.","journal-title":"J Clin Endocrinol Metab"},{"key":"2488_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010072","author":"YH Kim","year":"2019","unstructured":"Kim YH, Kim SM, Han KD, Jung JH, Lee SS, Oh SW, Park HS, Rhee EJ, Lee WY, Yoo SJ. Waist circumference and all-cause mortality independent of body mass index in korean population from the national health insurance health checkup 2009\u207b2015. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8010072.","journal-title":"J Clin Med"},{"key":"2488_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-023-00353-2","author":"F \u00c5berg","year":"2023","unstructured":"\u00c5berg F, F\u00e4rkkil\u00e4 M, Salomaa V, Jula A, M\u00e4nnist\u00f6 S, Perola M, Lundqvist A, M\u00e4nnist\u00f6 V. Waist-hip ratio is superior to BMI in predicting liver-related outcomes and synergizes with harmful alcohol use. Commun Med (Lond). 2023. https:\/\/doi.org\/10.1038\/s43856-023-00353-2.","journal-title":"Commun Med (Lond)"},{"key":"2488_CR14","doi-asserted-by":"publisher","unstructured":"Steven McGee. Evidence-based physical diagnosis (Fourth Edition). Elsevier. 2018; https:\/\/doi.org\/10.1016\/B978-0-323-39276-1.00013-5.","DOI":"10.1016\/B978"},{"key":"2488_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2336-9","author":"F Soriguer","year":"2012","unstructured":"Soriguer F, Goday A, Bosch-Comas A, Bordi\u00fa E, Calle-Pascual A, Carmena R, Casamitjana R, Casta\u00f1o L, Castell C, Catal\u00e1 M, Delgado E, Franch J, Gaztambide S, Girb\u00e9s J, Gomis R, Guti\u00e9rrez G, L\u00f3pez-Alba A, Mart\u00ednez-Larrad MT, Men\u00e9ndez E, Mora-Peces I, Ortega E, Pascual-Manich G, Rojo-Mart\u00ednez G, Serrano-Rios M, Vald\u00e9s S, V\u00e1zquez JA, Vendrell J. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012. https:\/\/doi.org\/10.1007\/s00125-011-2336-9.","journal-title":"Diabetologia"},{"key":"2488_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcg069","author":"DC Chan","year":"2003","unstructured":"Chan DC, Watts GF, Barrett PH, Burke V. Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men. QJM. 2003. https:\/\/doi.org\/10.1093\/qjmed\/hcg069.","journal-title":"QJM"},{"key":"2488_CR17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614362","author":"A Afshin","year":"2017","unstructured":"Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, Mokdad AH, Moradi-Lakeh M, Naghavi M, et al. GBD 2015 obesity collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017. https:\/\/doi.org\/10.1056\/NEJMoa1614362.","journal-title":"N Engl J Med"},{"key":"2488_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2024.04.001","author":"HE Bays","year":"2024","unstructured":"Bays HE, Kirkpatrick CF, Maki KC, Toth PP, Morgan RT, Tondt J, Christensen SM, Dixon DL, Jacobson TA. Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the obesity medicine association and the national lipid association 2024. J Clin Lipidol. 2024. https:\/\/doi.org\/10.1016\/j.jacl.2024.04.001.","journal-title":"J Clin Lipidol"},{"key":"2488_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbx170","author":"RK Azad","year":"2019","unstructured":"Azad RK, Shulaev V. Metabolomics technology and bioinformatics for precision medicine. Brief Bioinform. 2019. https:\/\/doi.org\/10.1093\/bib\/bbx170.","journal-title":"Brief Bioinform"},{"key":"2488_CR20","doi-asserted-by":"publisher","DOI":"10.1089\/met.2019.0047","author":"G Satheesh","year":"2020","unstructured":"Satheesh G, Ramachandran S, Jaleel A. Metabolomics-based prospective studies and prediction of Type 2 diabetes mellitus risks. Metab Syndr Relat Disord. 2020. https:\/\/doi.org\/10.1089\/met.2019.0047.","journal-title":"Metab Syndr Relat Disord"},{"key":"2488_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-38703-8","author":"PENR Bellot","year":"2023","unstructured":"Bellot PENR, Braga ES, Omage FB, da Silva Nunes FL, Lima SCVC, Lyra CO, Marchioni DML, Pedrosa LFC, Barbosa F Jr, Tasic L, Sena-Evangelista KCM. Plasma lipid metabolites as potential biomarkers for identifying individuals at risk of obesity-induced metabolic complications. Sci Rep. 2023. https:\/\/doi.org\/10.1038\/s41598-023-38703-8.","journal-title":"Sci Rep"},{"key":"2488_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-023-01921-0","author":"B Yu","year":"2023","unstructured":"Yu B, Hu M, Jiang W, Ma Y, Ye J, Wu Q, Guo W, Sun Y, Zhou M, Xu Y, Wu Z, Wang Y, Lam SM, Shui G, Gu J, Li JZ, Fu Z, Gong Y, Zhou H. Ceramide d18:1\/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes. Lipids Health Dis. 2023. https:\/\/doi.org\/10.1186\/s12944-023-01921-0.","journal-title":"Lipids Health Dis"},{"key":"2488_CR23","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-2402","author":"F Ottosson","year":"2022","unstructured":"Ottosson F, Smith E, Ericson U, Brunkwall L, Orho-Melander M, Di Somma S, Antonini P, Nilsson PM, Fernandez C, Melander O. Metabolome-defined obesity and the risk of future Type 2 diabetes and mortality. Diabetes Care. 2022. https:\/\/doi.org\/10.2337\/dc21-2402.","journal-title":"Diabetes Care"},{"key":"2488_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.09.022","author":"ET Cirulli","year":"2019","unstructured":"Cirulli ET, Guo L, Leon Swisher C, Shah N, Huang L, Napier LA, Kirkness EF, Spector TD, Caskey CT, Thorens B, Venter JC, Telenti A. Profound perturbation of the metabolome in obesity is associated with health risk. Cell Metab. 2019. https:\/\/doi.org\/10.1016\/j.cmet.2018.09.022.","journal-title":"Cell Metab"},{"key":"2488_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04244-x","author":"P Zhong","year":"2023","unstructured":"Zhong P, Tan S, Zhu Z, Bulloch G, Long E, Huang W, He M, Wang W. Metabolomic phenotyping of obesity for profiling cardiovascular and ocular diseases. J Transl Med. 2023. https:\/\/doi.org\/10.1186\/s12967-023-04244-x.","journal-title":"J Transl Med"},{"key":"2488_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013. https:\/\/doi.org\/10.1001\/jama.2013.281053.","journal-title":"JAMA"},{"key":"2488_CR27","unstructured":"WHO Consultation on Obesity,World Health Organization. Obesity: preventing and managing the global epidemic: report of a WHO consultation.World Health Organization. 2000. https:\/\/apps.who.int\/iris\/handle\/10665\/42330. Accessed 8 July 2024."},{"key":"2488_CR28","unstructured":"World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation. World Health Organization. 2011 https:\/\/www.who.int\/publications\/i\/item\/9789241501491. Accessed 11 June 2024."},{"key":"2488_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000107251.49515.c2","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003. https:\/\/doi.org\/10.1161\/01.HYP.0000107251.49515.c2.","journal-title":"Hypertension"},{"key":"2488_CR30","doi-asserted-by":"crossref","unstructured":"World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Diabet Med. 1998; doi: 10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"2488_CR31","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.D050120","author":"R Mallol","year":"2015","unstructured":"Mallol R, Amig\u00f3 N, Rodr\u00edguez MA, Heras M, Vinaixa M, Plana N, Rock E, Ribalta J, Yanes O, Masana L, Correig X. Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy. J Lipid Res. 2015. https:\/\/doi.org\/10.1194\/jlr.D050120.","journal-title":"J Lipid Res"},{"key":"2488_CR32","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.8b00411","author":"R Fuertes-Mart\u00edn","year":"2018","unstructured":"Fuertes-Mart\u00edn R, Taverner D, Vallv\u00e9 JC, Paredes S, Masana L, Correig Blanchar X, Amig\u00f3 Grau N. Characterization of 1H NMR plasma glycoproteins as a new strategy to identify inflammatory patterns in rheumatoid arthritis. J Proteome Res. 2018. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00411.","journal-title":"J Proteome Res"},{"key":"2488_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202306154","author":"A Mallagaray","year":"2023","unstructured":"Mallagaray A, Rudolph L, Lindloge M, M\u00f6lbitz J, Thomsen H, Schmelter F, Alhabash MW, Abdullah MR, Saraei R, Ehlers M, Graf T, Sina C, Petersmann A, Nauck M, G\u00fcnther UL. Towards a precise NMR quantification of acute phase inflammation proteins from human serum. Angew Chem Int Ed Engl. 2023. https:\/\/doi.org\/10.1002\/anie.202306154.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2488_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020354","author":"R Fuertes-Mart\u00edn","year":"2020","unstructured":"Fuertes-Mart\u00edn R, Correig X, Vallv\u00e9 JC, Amig\u00f3 N. Human serum\/plasma glycoprotein analysis by 1H-NMR, an emerging method of inflammatory assessment. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9020354.","journal-title":"J Clin Med"},{"key":"2488_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31832-5","author":"J Miranda","year":"2018","unstructured":"Miranda J, Sim\u00f5es RV, Paules C, Ca\u00f1ueto D, Pardo-Cea MA, Garc\u00eda-Mart\u00edn ML, Crovetto F, Fuertes-Martin R, Domenech M, G\u00f3mez-Roig MD, Eixarch E, Estruch R, Hansson SR, Amig\u00f3 N, Ca\u00f1ellas N, Crispi F. Gratac\u00f3s. Metabolic profiling and targeted lipidomics reveals a disturbed lipid profile in mothers and fetuses with intrauterine growth restriction. Sci Rep. 2018. https:\/\/doi.org\/10.1038\/s41598-018-31832-5.","journal-title":"Sci Rep"},{"key":"2488_CR36","doi-asserted-by":"publisher","DOI":"10.4158\/EP161365.GL","author":"WT Garvey","year":"2016","unstructured":"Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R. Reviewers of the AACE\/ACE obesity clinical practice guidelines. American Association of Clinical Endocrinologists and American Association of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016. https:\/\/doi.org\/10.4158\/EP161365.GL.","journal-title":"Endocr Pract"},{"key":"2488_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2018.11.005","author":"J Vekic","year":"2019","unstructured":"Vekic J, Zeljkovic A, Stefanovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V. Obesity and dyslipidemia. Metabolism. 2019. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.005.","journal-title":"Metabolism"},{"key":"2488_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.07.040","author":"CM Phillips","year":"2015","unstructured":"Phillips CM, Perry IJ. Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter? Atherosclerosis. 2015. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.07.040.","journal-title":"Atherosclerosis"},{"key":"2488_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9030242","author":"JT Stadler","year":"2021","unstructured":"Stadler JT, Lackner S, M\u00f6rkl S, Trakaki A, Scharnagl H, Borenich A, Wonisch W, Mangge H, Zelzer S, Meier-Allard N, Holasek SJ, Marsche G. Obesity affects HDL metabolism, Composition and Subclass Distribution. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9030242.","journal-title":"Biomedicines"},{"key":"2488_CR40","doi-asserted-by":"publisher","unstructured":"Hu X, Liu Q, Guo X, Wang W, Yu B, Liang B, Zhou Y, Dong H, Lin J. The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus. Cardiovasc Diabetol. 2022;2. https:\/\/doi.org\/10.1186\/s12933-022-01554-0.","DOI":"10.1186\/s12933-022-01554-0"},{"key":"2488_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13481","author":"A Manmadhan","year":"2019","unstructured":"Manmadhan A, Lin BX, Zhong J, Parikh M, Berger JS, Fisher EA, Heffron SP. Elevated GlycA in severe obesity is normalized by bariatric surgery. Diabetes Obes Metab. 2019. https:\/\/doi.org\/10.1111\/dom.13481.","journal-title":"Diabetes Obes Metab"},{"key":"2488_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa1011","author":"J Schubert","year":"2021","unstructured":"Schubert J, Lindahl B, Melhus H, Renlund H, Leosdottir M, Yari A, Ueda P, James S, Reading SR, Dluzniewski PJ, Hamer AW, Jernberg T, Hagstr\u00f6m E. Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study. Eur Heart J. 2021. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1011.","journal-title":"Eur Heart J"},{"key":"2488_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv028","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Cariou B, Blom D, McKenney JM, Lorenzato C, Pordy R, Chaudhari U, Colhoun HM. ODYSSEY COMBO II Investigators. Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial. Eur Heart J. 2015. https:\/\/doi.org\/10.1093\/eurheartj\/ehv028.","journal-title":"Eur Heart J"},{"key":"2488_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110772","author":"E Ozcariz","year":"2023","unstructured":"Ozcariz E, Guardiola M, Amig\u00f3 N, Rojo-Mart\u00ednez G, Vald\u00e9s S, Rehues P, Masana L, Ribalta J. NMR-based metabolomic profiling identifies inflammation and muscle-related metabolites as predictors of incident type 2 diabetes mellitus beyond glucose: The Di@bet.es study. Diabetes Res Clin Pract. 2023. https:\/\/doi.org\/10.1016\/j.diabres.2023.110772.","journal-title":"Diabetes Res Clin Pract"},{"key":"2488_CR45","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20090928","author":"F Wang","year":"2009","unstructured":"Wang F, Liu H, Blanton WP, Belkina A, Lebrasseur NK, Denis GV. Brd2 disruption in mice causes severe obesity without Type 2 diabetes. Biochem J. 2009. https:\/\/doi.org\/10.1042\/BJ20090928.","journal-title":"Biochem J"},{"key":"2488_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.114.000216","author":"P Soininen","year":"2015","unstructured":"Soininen P, Kangas AJ, W\u00fcrtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet. 2015. https:\/\/doi.org\/10.1161\/CIRCGENETICS.114.000216.","journal-title":"Circ Cardiovasc Genet"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02488-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02488-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02488-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T12:02:01Z","timestamp":1730980921000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02488-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2488"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02488-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5026876\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all the participants. The study was approved by the Ethics and Clinical Investigation Committee of the Hospital Regional Universitario de M\u00e1laga (M\u00e1laga, Spain) in addition to other regional ethics and clinical investigation committees all over Spain.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N.A. is stock owner of Biosfer Teslab and has a patent on the method for lipoprotein profiling described in the present manuscript. E.O. was employed at Biosfer Teslab. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}}],"article-number":"402"}}